Regulatory
FDA updates Congress on CBD, but CBD’s legal pathway still in limbo
March 6th 2020FDA’s March 5 CBD report to Congress, required by the 2020 spending bill, focused mainly on the agency’s progress in collecting data on CBD, but provided no new material information on whether the agency will make CBD a legal dietary ingredient.
Pharmactive Biotech’s saffron and black garlic extracts receive organic certifications
February 17th 2020The Committee of Ecological Agriculture of Madrid has granted organic certification to Pharmactive Biotech Products’ range of saffron-based formulations, affron and affronEYE, as well as its aged black garlic extract, ABG10+.
Ingredients by Nature receives patent approval for use of eriocitrin to support blood glucose
February 12th 2020The U.S. Patent and Trademark Office has approved a patent for the use of eriocitrin in Ingredient By Nature’s ingredient formulations, such as Eriomin, a citrus flavonoid designed for blood glucose support.
Polyphenol-rich extract received authorized health claim in South Korea
February 11th 2020The South Korean Ministry of Food and Drug Safety has recognized the effects of Memophenol, a patented formulation of grape and blueberry polyphenols, on cognitive performance, specifically memory, with an authorized health claim.
Best-selling omega-3 supplements comply with regulatory requirements, says GOED study
January 29th 2020GOED tested the quality of 48 of the most-widely sold EPA/DHA omega-3 supplements in the US. Quality was determined by testing the EPA/DHA content of the products, and comparing it labeled content on the bottle.
FDA approves at-home blood collection process from Baze, a personalized nutrition company
January 24th 2020Baze’s at-home blood testing kits assess consumers’ blood nutrient status, which Baze then analyzes using its Nutrition Information System to offer nutrition plans and curate supplement subscriptions.
New bill would allow hemp-derived CBD to be marketed as a dietary supplement
January 14th 2020Collin Peterson (D-MN), the House Agriculture Committee Chairman, introduced legislation designed to provide FDA with the flexibility to allow hemp-derived cannabidiol (CBD) to be marketed in dietary supplements.